- STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concernsAbivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.STAT · 1mo ago↗ source
- STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeawaysHere is some of what you may have missed from the world's largest cancer research meeting.STAT · 1mo ago↗ source
- STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to griefAt the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.STAT · 1mo ago↗ source